N-(4-pyridyl) methyl carbamate inhibits fast potassium currents in guinea pig dorsal root ganglion cells

Journal of the Neurological Sciences

Volumn 277, Issue 1-2, 2009, Pages 114-118

  Sun, Wenjing ^a   Smith, Daniel ^c   Bryn, Steven ^c   Borgens, Richard ^a,b   Shi, Riyi ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b Weldon School of Engineering   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

Compound action potential; Conduction block; Dorsal root ganglion; Myelin damage; Patch clamp

Indexed keywords

4 PYRIDYLMETHYLCARBAMIC ACID; CARBAMIC ACID DERIVATIVE; POTASSIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEMYELINATION; DRUG EFFICACY; DRUG INHIBITION; FEMALE; GUINEA PIG; MULTIPLE SCLEROSIS; NERVE CONDUCTION; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; SPINAL CORD INJURY; SPINAL GANGLION; WHOLE CELL;

4-AMINOPYRIDINE; ANIMALS; CARBAMATES; FEMALE; GANGLIA, SPINAL; GUINEA PIGS; MEMBRANE POTENTIALS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; PYRIDINES; SENSORY RECEPTOR CELLS;

EID: 58149291832     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.10.028     Document Type: Article

References (36)

1. Cao Q., Zhang Y.P., Iannotti C., DeVries W.H., Xu X.M., Shields C.B., et al. Functional and electrophysiological changes after graded traumatic spinal cord injury in adult rat. Exp Neurol 191 Suppl 1 (2005) S3-S16
2. Bunge R.P., Bunge M.B., and Ris H. Electron microscopic study of demyelination in an experimentally induced lesion in adult cat spinal cord. J Biophys Biochem Cytol 7 (1960) 685-696
3. Blight A.R., and DeCrescito V. Morphometric analysis of experimental spinal cord injury in the cat: the relation of injury intensity to survival of myelinated axons. Neuroscience 19 (1986) 321-341
4. Judge S.I., and Bever Jr. C.T. Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther 111 (2006) 224-259
5. Wang H., Kunkel D.D., Martin T.M., Schwartzkroin P.A., and Tempel B.L. Heteromultimeric K+ channels in terminal and juxtaparanodal regions of neurons. Nature 365 (1993) 75-79
6. Poliak S., and Peles E. The local differentiation of myelinated axons at nodes of Ranvier. Nat Rev Neurosci 4 (2003) 968-980
7. Sasaki M., Black J.A., Lankford K.L., Tokuno H.A., Waxman S.G., and Kocsis J.D. Molecular reconstruction of nodes of Ranvier after remyelination by transplanted olfactory ensheathing cells in the demyelinated spinal cord. J Neurosci 26 (2006) 1803-1812
8. Shi R., and Blight A.R. Differential effects of low and high concentrations of 4-aminopyridine on axonal conduction in normal and injured spinal cord. Neuroscience 77 (1997) 553-562
9. Shi R., Kelly T.M., and Blight A.R. Conduction block in acute and chronic spinal cord injury: different dose-response characteristics for reversal by 4-aminopyridine. Exp Neurol 148 (1997) 495-501
10. Jensen J.M., and Shi R. Effects of 4-aminopyridine on stretched mammalian spinal cord: the role of potassium channels in axonal conduction. J Neurophysiol 90 (2003) 2334-2340
11. Hayes K.C., Potter P.J., Wolfe D.L., Hsieh J.T., Delaney G.A., and Blight A.R. 4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury. J Neurotrauma 11 (1994) 433-446
12. Hayes K.C., Katz M.A., Devane J.G., Hsieh J.T., Wolfe D.L., Potter P.J., et al. Pharmacokinetics of an immediate-release oral formulation of Fampridine (4-aminopyridine) in normal subjects and patients with spinal cord injury. J Clin Pharmacol 43 (2003) 379-385
13. Hayes K.C., Potter P.J., Hsieh J.T., Katz M.A., Blight A.R., and Cohen R. Pharmacokinetics and safety of multiple oral doses of sustained-release 4-aminopyridine (Fampridine-SR) in subjects with chronic, incomplete spinal cord injury. Arch Phys Med Rehabil 85 (2004) 29-34
14. Kocsis J.D. Aminopyridine-sensitivity of spinal cord white matter studied in vitro. Exp Brain Res 57 (1985) 620-624
15. Blight A.R., Toombs J.P., Bauer M.S., and Widmer W.R. The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: a phase I clinical trial. J Neurotrauma 8 (1991) 103-119
16. Stork C.M., and Hoffman R.S. Characterization of 4-aminopyridine in overdose. J Toxicol Clin Toxicol 32 (1994) 583-587
17. van der Bruggen M.A., Huisman H.B., Beckerman H., Bertelsmann F.W., Polman C.H., and Lankhorst G.J. Randomized trial of 4-aminopyridine in patients with chronic incomplete spinal cord injury. J Neurol 248 (2001) 665-671
18. Segal J.L., Pathak M.S., Hernandez J.P., Himber P.L., Brunnemann S.R., and Charter R.S. Safety and efficacy of 4-aminopyridine in humans with spinal cord injury: a long-term, controlled trial. Pharmacotherapy 19 (1999) 713-723
19. Smith D.T., Shi R., Borgens R.B., McBride J.M., Jackson K., and Byrn S.R. Development of novel 4-aminopyridine derivatives as potential treatments for neurological injury and disease. Eur J Med Chem 40 (2005) 908-917
20. McBride J.M., Smith D.T., Byrn S.R., Borgens R.B., and Shi R. Dose responses of three 4-aminopyridine derivatives on axonal conduction in spinal cord trauma. Eur J Pharm Sci 27 (2006) 237-242
21. McBride J.M., Smith D.T., Byrn S.R., Borgens R.B., and Shi R. 4-Aminopyridine derivatives enhance impulse conduction in guinea-pig spinal cord following traumatic injury. Neuroscience 148 (2007) 44-52
22. McFarlane S., and Cooper E. Kinetics and voltage dependence of A-type currents on neonatal rat sensory neurons. J Neurophysiol 66 (1991) 1380-1391
23. Akins P.T., and McCleskey E.W. Characterization of potassium currents in adult rat sensory neurons and modulation by opioids and cyclic AMP. Neuroscience 56 (1993) 759-769
24. Everill B., Rizzo M.A., and Kocsis J.D. Morphologically identified cutaneous afferent DRG neurons express three different potassium currents in varying proportions. J Neurophysiol 79 (1998) 1814-1824
25. Stewart T., Beyak M.J., and Vanner S. Ileitis modulates potassium and sodium currents in guinea pig dorsal root ganglia sensory neurons. J Physiol 552 (2003) 797-807
26. Tan Z.Y., Donnelly D.F., and LaMotte R.H. Effects of a chronic compression of the dorsal root ganglion on voltage-gated Na+ and K+ currents in cutaneous afferent neurons. J Neurophysiol 95 (2006) 1115-1123
27. Shi R., and Blight A.R. Compression injury of mammalian spinal cord in vitro and the dynamics of action potential conduction failure. J Neurophysiol 76 (1996) 1572-1580
28. Xu G.Y., Winston J.H., Shenoy M., Yin H., and Pasricha P.J. Enhanced excitability and suppression of A-type K+ current of pancreas-specific afferent neurons in a rat model of chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol 291 (2006) G424-431
29. Vydyanathan A., Wu Z.Z., Chen S.R., and Pan H.L. A-type voltage-gated K+ currents influence firing properties of isolectin B4-positive but not isolectin B4-negative primary sensory neurons. J Neurophysiol 93 (2005) 3401-3409
30. Everill B., Rizzo M.A., and Kocsis J.D. Morphologically identified cutaneous afferent DRG neurons express three different potassium currents in varying proportions. J Neurophysiol 79 (1998) 1814-1824
31. Shi R., and Blight A.R. Differential effects of low and high concentrations of 4-aminopyridine on axonal conduction in normal and injured spinal cord. Neuroscience 77 (1997) 553-562
32. Shi R., Kelly T.M., and Blight A.R. Conduction block in acute and chronic spinal cord injury: Different dose-response characteristics for reversal by 4-Aminopyridine. Exp Neurol 148 (1997) 495-501
33. van Diemen H.A., Polman C.H., van Dongen M.M., Nauta J.J., Strijers R.L., van Loenen A.C., et al. 4-Aminopyridine induces functional improvement in multiple sclerosis patients: a neurophysiological study. J Neurol Sci 116 (1993) 220-226
34. Stefoski D., Davis F.A., Faut M., and Schauf C.L. 4-Aminopyridine improves clinical signs in multiple sclerosis. Ann Neurol 21 (1987) 71-77
35. Fujihara K., and Miyoshi T. The effects of 4-aminopyridine on motor evoked potentials in multiple sclerosis. J Neurol Sci 159 (1998) 102-106
36. Judge S.I., Lee J.M., Bever Jr. C.T., and Hoffman P.M. Voltage-gated potassium channels in multiple sclerosis: overview and new implications for treatment of central nervous system inflammation and degeneration. J Rehabil Res Dev 43 (2006) 111-122